MedTrace Logo

Vessel Wall Response of the Bio-Active-stent and Everolimus-Eluting Stent Assessed By Optical Coherence Tomography

NCT01080859 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2011-05-05

No results posted yet for this study

Summary

The purpose of the trial is to evaluate the completeness of struts coverage and vessel wall response (strut malapposition, neoin-timal formation) to the bio-active-stent (BAS) versus ever-olimus-eluting stent (EES) implanted for the treatment of the culprit lesion in acute coronary syndrome.

Conditions

  • Acute Coronary Syndrome

Interventions

DEVICE

OCT

Optical coherence tomography

DEVICE

OCT

Optical coherence tomography

Sponsors & Collaborators

  • The Hospital District of Satakunta

    lead OTHER

Principal Investigators

  • Pasi P Karjalainen, MD, PhD · Satakunta Central Hospital, Pori, Finland

  • Antti Ylitalo, MD, PhD · Satakunta Central Hospital, Pori, Finland

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01080859 on ClinicalTrials.gov